FAM20C and amelogenesis imperfecta type 1G: Surprisingly, ERS patients do not suffer from constitutional bone diseases (Jaureguiberry et al., 2012) such as osteosclerosis indicating that FAM20A does not participate predominantly in the secretion of FAM20C in the developing bone.